Ferrous Sulphate Heptahydrate (99.5%) - India CAS: 7782-63-0
Related Insights
Steam Cracker Economics: How China's High Utilization Is Squeezing European Petrochemical Producers
Chinese steam crackers operating near maximum capacity can spread fixed costs across larger output volumes and export surplus petrochemicals into global markets. European crackers averaging around 75% utilization face a widening cost disadvantage that could reshape polymer pricing, regional production and procurement strategies
Electronic Chemicals and the Helium Structural Deficit: Planning for 3–5 Years of Qatari Capacity Loss
The expected 3–5-year reduction in Qatar's helium production is reshaping global supply chains. Learn how semiconductor, pharmaceutical, and healthcare industries can prepare for long-term helium shortages.
Navigating Drug Shortages: Using IMO Incident Data to Mitigate Strait of Hormuz Supply Risks
The IMO dataset of 49 confirmed maritime incidents gives hospital pharmacy teams a structured roadmap to assess pharmaceutical exposure in the Gulf. By mapping API and chemical routes against high‑risk zones, procurement leaders can strategically plan Q3 logistics and safeguard patient care.
Sucralose Market Outlook 2026: GLP-1 Era Drives New Demand Patterns and H2 Supply Trends
The sucralose market is entering a new phase in H2 2026 as changing consumer behavior linked to GLP-1 weight management therapies supports demand for low-calorie sweetness solutions. Food and beverage manufacturers are reassessing sourcing strategies as Chinese supply conditions, freight costs and contract negotiations shape delivered pricing.
Maltodextrin & Dextrose Market Outlook H2 2026: Sports Nutrition Demand Drives Global Sourcing
With sports nutrition surging, maltodextrin and dextrose demand is set to rise in H2 2026. Easing freight rates unlock new procurement windows, especially in China and emerging markets. This article explores market dynamics, supply trends, and strategic sourcing tips for buyers.
Drug Shortage Risk Intelligence: June 24 Status Update
Drug shortage risk remains elevated in H2 2026 despite easing Hormuz tensions. Pharmaceutical procurement teams should prioritize safety stock updates, secondary supplier qualification, and stronger force majeure protections to secure supply continuity into 2027.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.